Abstract
Iron limitation induces the expression of iron-regulated outer-membrane proteins, which are not expressed under iron sufficient growth conditions. In the present study, these proteins were purified in order to evaluate their protective potential in the experimental model. Anti IROMPs antiserum was raised in rabbits. In mice, passively transferred anti-IROMPs antibodies provided 60% protection against the serovar Typhi challenge dose (9.6 LD50). The hyperimmune serum containing anti-IROMPs antibodies were also found to be bactericidal in the presence of complement whereas no bacterial killing was observed with pre-immunized serum. Bactericidal titre of anti-IROMPs serum was fond to be 2000 as more than 50% killing was observed with serum diluted to 1:2000. The role of IROMPs was assessed in actively-immunized mice followed by challenge with serovar Typhi. These proteins provided protection in 90% mice against challenge (480 LD50) with the pathogen. The levels of isotypes of antibodies (IgG, IgM & IgA) in the sera and secretory antibodies (sIgA) in the gut fluid of immunized mice correlated with the protection. This study, thus indicates that anti IROMPs antibodies may play an important role in providing protection at systemic as well as at mucosal level.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Harrison JA, Villarreal-Ramos B, Mastroeni P: Correlates of protection induced by live Aro Salmonella typhimurium vaccines in the murine typhoid model. Immunology 90: 618–625, 1997
Lowe DC, Sevidge TC, Pickard D, Eckmann L, Kagnoff HF, Dougan G, Chatfied SN: Characterization of candidate live oral Salmonella typhi vaccine strains harboring defined mutations in aro A, aro C and hrt A. Infect Immun 67: 700–707, 1999
Wandel G: Efficacy of S. typhi Vi Capsular polysaccharide vaccine in South Africa. Vaccine 15: 1815, 1997
Klugman KP, Koornhof HJ, Gilbertson IJ, Robbins JB, Schmeerson Schulz D, Cadoz M, Armand J: Vaccine advisory committee. Protective efficacy of Vi-capsular polysaccharide vaccine against typhoid fever. Lancet 2: 1165–1169, 1987
Singh M, Ganguly NK, Kumar L, Vohra H: Protective efficacy and immunogenicity of Vi-porin conjugate against Salmonella typhi. Microbiol Immunol 43: 535–542, 1999
Tiwari RP, Gupta W, Rishi P: Immunobiology of lipopolysaccharide (LPS) and LPS-derived immunoconjugates vaccinate mice against Salmonella typhimurium. Microbiol Immunol 42: 1–5, 1998
Alurkar V, Kamat R: Immunomodulatory properties of porins of some members of the family Enterobacteriaceae. Infect Immun 65: 2382–2388, 1997
Isibasi A, Paniagua J, Rojo MP, Martin M, Ramirej G, Gonzalez CR, Lopes MC, Sanches J, Kumate J, Ortiz V: Role of porins from S. typhi in the induction of protective immunity. Ann NY Acad Sci 730: 350–352, 1994
Sharma (Rishi) P, Ganguly NK, Sharma BK, Sharma S, Sehgal R: Specific immunoglobulin response in mice immunized with porins and challenged with S. typhi. Microbiol Immunol 33: 519–525, 1989
Payne SM: Iron and virulence in the family enterobacteriaceae. Crit Rev Microbiol 16: 81–111, 1988
Litwin CM, Calderwood SB: Role of iron in regulation of virulence genes. Clin Microbiol Rev 6: 137–149, 1993
Martinez JLA, Delgado-Iribarren A, Baquero F: Mechanism of iron acquisition and bacterial virulence. FEMS Microbiol Rev 75: 45–56, 1990
Weinberg ED: Iron withholding: A defense against infection and disease. Physiol Rev 4: 65–102, 1984
Rishi P, Woodward CL, Kim WK, Ricke SC: Salmonella enterica serovar Typhimurium hilA-lacZY fusion gene response to iron chelation in rich and minimal media. J Environ Sci Health B39(5–6): 861–870, 2004
Anthony AC, Thomas FD, Catherine AR: Outer membrane protein B1, an iron repressible protein conserved in the outer membrane of Moraxella catarrhalis, binds human transferrin. Infect Immun 64: 3920–3924, 1996
Mietzner TA, Morse SA: The role of iron binding proteins in the survival of pathogenic bacteria. Am Rev Nutr 14: 471–493, 1994
Worst DJ, Otto BR, De Graff J: Iron represible outer membrane proteins of Helicobacter pylori involved in heme uptake. Infect Immun 63: 4161–4165, 1995
Morton D, Williams P: Characterization of the OMPs of Haemophilus parainfluenzae expressed under iron-sufficient and iron restricted conditions. J Gen Microbiol 135: 445–451, 1989
Shand GH, Anwar H, Kadurugamuwa JL, Brown MRW, Silverman SH, Melling J: In vivo evidence that bacteria in urinary tract infection grow under iron-restricted conditions. Infect Immun 48: 35–39, 1985
Thomas SL, Jacqueline DF, Robert RB, Robert DP: Iron uptake and iron repressible polypeptides in Yersinia pestis. Infect Immun 64: 3023–3031, 1996
Cornellison CN, Kelley M, Hobbs MM, Anderson JE, Common JG, Cohen MS, Sparling PF: The transferrin receptor expressed by gonococcal strain FA 1090 is required for the experimental infection of human male volunteers. Mol Microbiol 27: 611–616, 1998
Otto BR, Verweij WR, Sparrius M, Verweiz-van AMJJ, Nord CE, MacLaren DM: Human immune response to an iron repressible outer membrane protein of Bacteroidis fragilis. Infect Immun 59: 2999–3003, 1991
Piccni CD, Barbe FM, Legnani-Fajardo CL: Identification of IROMPs in uropathogenic Proteus mirabilis and its relationship with heme uptake. FEMS Microbiol Lett 166: 243–248, 1998
Sood S, Rishi P, Sharma S, Sapru S, Ganguly NK: Expression of iron regulated outer membrane proteins in S. typhi grown in soild media. Med Sci Res 27: 6–13, 1999
Fernandez Beros ME, Gonzalez C, McIntosh MA, Cabello FC: Immune response to the iron-deprivation induced proteins of Salmonella typhi in typhoid fever. Infect Immun 57: 1271–1275, 1989
Carter P: Spectrophotometric analysis of serum iron at the submicrogram lovel with a new reagent (ferrozine). Anal Biochem 40: 450–458, 1971
Petterson A, Mass A, Wassenaar-van D, Ley-van-der P, Tomonassen J: Molecular characterization of FrpB, the 70 kD iron-regulated outer membrane protein of Neisseria meningitidis. Infect Immun 63: 4181–4184, 1995
Laemmli UK: Cleavage of structural proteins during the assembly of head of bacteriophage T4. Nature 227: 680–685, 1970
Hager DA Burgess RR: Elution of proteins from SDS-PAGE gels. Removal of SDS and renaturation of enzyme activity. Anal Biochem 109: 76–86, 1980
Piotrowicz BJ, Edlin SE, McCartney AC: A sensitive chromogenic limulus amoebocyte lysate microassay for detection of endotoxin in human plasma and in water. Bact Microbiol Hyg A260: 108–112, 1985
Bolin JA, Jenson AE: Passive immunization with antibodies against iron-regulated outer membrane proteins protects turkeys from E. coli septicemia. Infect Immun 55: 1239–1242, 1987
Muthukkumar S, Muthukkaruppan VR: Mechanism of protective immunity induced by porin lipopolysaccharide against murine salmonellosis. Infect Immun 61: 3017–3025, 1993
Reed IJ, Muench HA: A simple method of estimating fifty percent points. Am J Hyg 27: 493–499, 1998
Chen D, McMichael JC, Vandermeid KR, Hahn D, MinniniT, Cowell J, Eldridge J: Evaluation of purified Usp A from Moraxella catarrhalis as a vaccine in a murine model after active immunization. Infect Immun 64: 1900–1905, 1996
Forrest BD: Identification of an intestinal immune response using peripheral blood lymphocytes. Lancet 16: 81–83, 1988
Kuby J: In: Immunology, 3rd edn., Freedman WH and Co., New York, 1997
Szu SC, Stone AL, Robins FD, Schmerrson R, Robbins JB: Vi-capsular polysaccharide protein conjugates for prevention of typhoid fever. J Exp Med 66: 1510–1517, 1987
Carniel E, Antoine JC, Guiyoule A, Guiro N, Mollart HH: Purification, localization and immunological characterization of the iron-regulated high molecular weight proteins of highly pathogenic Yersinia. Infect Immun 57: 540–545, 1989
Von Spect BV, Lucking C, Blum B, Schmitt A, Hungerer KD, Domdey H: Safety and immunogenicity of a Pseudomonas aeruginosa outer membrane protein I vacccine in human volunteers. Vaccine 14: 1111–1117, 1996
Yokoyama H, Paralta RC, Diaz R, Sendo S, Ikemori Y, Kodama Y: Passive protective effect of chicken egg yolk immunoglobulins against experimental enterotoxigenic Escherichia coli infection in neonatal piglets. Infect Immun 60: 998–1007, 1992
Eisenstein TK, Killer LM, Sultzer BM: Immunity to infection with S. typhimurium. Mouse strain differences in vaccine and serum mediated protection. J Infect Dis 150: 425–435, 1984
Phalipan A, Kaufmann M, Michetti P, Cavallion JM, Huerre M, Sansonetti P, Kraehenbaul JP: Monoclonal IgA antibody directed against serotype specific epitope of Shigella flexneri LPS protects against experimental shigellosis. J Exp Med 182: 769–778, 1995
Doyle DS, Crabb J, Petterson C: Anti Cryptosporidium parvium antibodies inhibit infectivity in vitro and in vivo. Infect Immun 61: 4079–4084, 1993
Michell P, Porta N, Mahan MJ, Slauch JM, Mckalanos: Monoclonal IgA prevents adherence and invasion of polarized epithelial cell monolayers by Salmonella typhimurium. Gastroenterology 107: 915–923, 1994
Brown EJ, Joiner KA, Frank MM:. The role of complement in host resistance to bacteria. Springer Semin Immunopathol 6: 349–360, 1983
Ala’Aldeen A, Stevenson P, Griffiths E, Gorringe RA, Irons IL, Robinson A, Hyde S, Borriello PS: Immune response in humans and animals to meningococcal transferrin binding proteins: Implications for vaccine design. Infect Immun 62: 2984–2990, 1994
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sood, S., Rishi, P., Dhawan, V. et al. Protection mediated by antibodies to iron-regulated outer-membrane proteins of S. typhi in a mouse peritonitis model. Mol Cell Biochem 273, 69–78 (2005). https://doi.org/10.1007/s11010-005-7756-8
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11010-005-7756-8